Cargando…

Editorial: Kinase inhibitors in cancer therapy

Detalles Bibliográficos
Autor principal:	Yadav, Dharmendra Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660224/ https://www.ncbi.nlm.nih.gov/pubmed/36393866 http://dx.doi.org/10.3389/fcell.2022.1020297

Ejemplares similares

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021)

Editorial: Diacylglycerol Kinase Signalling
por: Merida, Isabel, et al.
Publicado: (2017)

Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022)

Editorial: Mitogen Activated Protein Kinases
por: Cuenda, Ana, et al.
Publicado: (2017)

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance
por: Patel, Girijesh Kumar, et al.
Publicado: (2023)

Editorial: The Roles of Oncogenic Phosphatase/Kinase in Tumors
por: Galiè, Mirco
Publicado: (2022)

Editorial: Novel Insights Into the Multifaceted Mitotic Kinases
por: Elowe, Sabine
Publicado: (2019)

Editorial: Targeted therapies for aggressive cancers
por: Lee, Sean B., et al.
Publicado: (2023)

Editorial: Tumor microenvironment and cancer therapy
por: Xie, Yi, et al.
Publicado: (2023)

Editorial: Cell Death and Targeted Cancer Therapies
por: Bagci-Onder, Tugba, et al.
Publicado: (2022)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
por: Li, Guo, et al.
Publicado: (2020)

Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologies
por: Sousa, Ângela, et al.
Publicado: (2023)

Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

Editorial: Cell therapy, liver diseases, and regeneration
por: Zhang, Wencheng, et al.
Publicado: (2022)

Acylglycerol Kinase-Targeted Therapies in Oncology
por: Chu, Binxiang, et al.
Publicado: (2021)

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance
por: Ruocco, Maria Rosaria, et al.
Publicado: (2022)

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
por: Tu, Bin, et al.
Publicado: (2020)

Editorial: Inflammation and Myeloid Cells in Cancer Progression and Metastasis
por: Mishra, Sanjay, et al.
Publicado: (2022)

Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
por: Vergani, Elisabetta, et al.
Publicado: (2022)

Editorial: Tissue Engineering and Cell Therapy for Cartilage Restoration
por: Fernandes, Tiago Lazzaretti, et al.
Publicado: (2022)

Editorial: Skeletal muscle—From developmental concepts to therapy
por: Dietrich, Susanne, et al.
Publicado: (2023)

Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine
por: Pützer, Brigitte M., et al.
Publicado: (2022)

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Dong, Xing-Duo, et al.
Publicado: (2020)

Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy
por: Xu, Dazhong, et al.
Publicado: (2021)

Editorial: Metabolism and Cell Adhesion in Cancer
por: Hartmann, Tanja Nicole
Publicado: (2022)

Editorial: Molecular Mechanisms of Autophagy in Cancer
por: Humbert, Magali, et al.
Publicado: (2022)

Editorial: The Use of Organoids in Cancer Biology
por: Xue, Xiang, et al.
Publicado: (2022)

Editorial: Epigenetic Reprogramming and Cancer Development
por: Brown, Geoffrey, et al.
Publicado: (2020)

Editorial: The development of lethal prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2023)

Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research
por: Hernandez, Diana, et al.
Publicado: (2022)

Editorial: New insights into molecular mechanisms and targeted therapy for gastrointestinal tumors
por: Feng, Haoran, et al.
Publicado: (2023)

Editorial: Cellular reprogramming in development, disease, and design of cell-replacement therapies
por: Burke, Zoë D., et al.
Publicado: (2023)

Mitogen-activated protein kinase kinase 7 in inflammatory, cancer, and neurological diseases
por: Caliz, Amada D., et al.
Publicado: (2022)

Editorial: Biomimetic Materials for Tissue Regenerations
por: Rajan, Mariappan, et al.
Publicado: (2022)

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
por: Deng, Jingjing, et al.
Publicado: (2022)

Editorial: TGF-β and BMP signaling in cancer
por: Yan, Xiaohua, et al.
Publicado: (2022)

Editorial: Hedgehog signaling pathway in development and cancer
por: Cheng, Steven Y., et al.
Publicado: (2022)

Editorial: Epithelial to Mesenchymal Plasticity in Colorectal Cancer
por: Bocci, Federico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nplolji5cv8725ncketgq881bg